万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>期刊大全 >>SCI/SCIE期刊 >>医药卫生>>五官科学

Auris Nasus Larynx(研究方向:耳鼻喉科学) (官网投稿)

简介
Auris Nasus Larynx(季刊),创刊于1973年,出版国家为荷兰。国际期刊Auris Nasus Larynx提供了有关耳鼻咽喉科和相关领域的基础和临床方面的快速,仔细审查的出版物的机会。这包括耳科学,神经学,支气管病理学,喉科学,鼻窦学,过敏症,头颈部医学和肿瘤手术,颌面和整形手术,听力学,言语科学。
本刊为:SCIE期刊(2015-2016), 外文期刊,
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

https://www.journals.elsevier.com/auris-nasus-larynx/

3、期刊投稿:

https://www.evise.com/profile/#/ANL/login

4、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

201753日星期三

                     

 

Author Guidelines

 

Scope

 

Auris Nasus Larynx provides the opportunity for rapid, carefully reviewed publications concerning the fundamental and clinical aspects of otorhinolaryngology and related fields. This includes otology, neurotology, bronchoesophagology, laryngology, rhinology, allergology, head and neck medicine and oncologic surgery, maxillofacial and plastic surgery, audiology, speech science and communication disorders.

 

Types of paper

 

Original papers and original case reports can be submitted. Thorough and detailed reviews on recent developments and Letters to the Editor commenting on papers or any aspect of the Journal are welcomed.

 

Original papers should report the results of original research, and the material should not have been previously published elsewhere, except in preliminary form. Manuscripts should be as concise and to the point as possible. Please condense your manuscript as much as possible. It is recommended that papers should in general not exceed 10 printed pages.Manuscript reporting randomized controlled trials should be submitted with CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT checklist and template of flow diagram can be found on http://www.consort-statement.org/.

 

Case reports should describe truly unique and/or educationally valuable cases, which provide benefits for future patients. Text should be limited to 1800 words (6 double-spaced typewritten pages) including an abstract, with no more than 15 references and a maximum of 4 figures/tables. An abstract for case reports should not exceed 200 words and should not have a structured format.

 

Online Submission of Manuscripts http://ees.elsevier.com/anl.

 

Submission and peer review of all papers is now conducted entirely online using the dedicated site at http://ees.elsevier.com/anl

 

Authors are required to register upon using the system for the first time. Authors are guided stepwise through the entire process, and are kept abreast of the progress of their paper at each stage.

 

The system creates a PDF version of the submitted manuscript for peer review, revision and proofing. All correspondence, including the Editor's decision and request for revisions, is conducted by e-mail.

 

Further Information and Support

 

Authors requesting further information on online submission are strongly encouraged to view an online tutorial, at http://ees.elsevier.com/anl or visit our customer support site at http://support.elsevier.com

 

Submission of Manuscripts: Originality and Copyright

 

Submission of an article is understood to imply that the article is original and is not being considered for publication elsewhere. Upon acceptance of the article by the journal, the author(s) will be asked to transfer the copyright of the article to the publisher. This transfer will ensure the widest possible dissemination of information.

 

Multiple Authorship

 

On submission, all authors of the paper listed should sign a letter in which they state that they all have participated sufficiently in the conception and design of the work, in the analysis of the data and in writing the manuscript to take public responsibility for it.

 

Clinical trial

 

Any clinical trial must be registered in a publicly accessible database. Auris Nasus Larynx requires that authors provide the name of the trial's registry and their clinical trial registration number at the end of the abstract. This is valid for submission on or after February 21, 2014. Auris Nasus Larynx follows recommendations of the International Committee of Medical Journal Editors (ICMJE)(http://www.icmje.org/).Purely observational studies will not require registration.

 

编辑委员会

主编

t .中川

日本福冈

副主编

t . Himi

日本札幌

执行董事会成员(编辑)

川内h .

,日本

编辑委员会

美国Fujieda

日本福井县

o . Fujioka

日本川崎重工

:Hara

日本茨城县

美国Haruna

日本枥木

y Iino

日本东京

h . Inohara

日本大阪

川内h .

Shiname,日本

Koizuka

日本川崎重工

y Kurono

鹿儿岛,日本

h·本森山

日本东京

t .中川

日本福冈

k . Nishizaki

日本冈山

英国小川

日本东京

t . Okuno

日本东京

k . Omori

日本京都

m . Sakagami

日本兵库县

h .高桥

长崎,日本

逐句翻译


投稿问答最小化  关闭